MSH2 and non-small cell lung carcinoma: In a study of 150 cases of NSCLC, Xinarianos et al.16 have found reduced expression of MLH1 protein in 58.6% of cases, MSH2 in 57.8% and either MLH1 or MSH2 in 82%.